Rifasutenizol
Antibiotic medication
| Rifasutenizol | |
|---|---|
[[File: | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Rifasutenizol is a broad-spectrum antibiotic used primarily in the treatment of bacterial infections. It belongs to the class of antibiotics known as rifamycins, which are known for their effectiveness against Mycobacterium tuberculosis and other mycobacteria.
Mechanism of Action[edit]
Rifasutenizol works by inhibiting bacterial RNA polymerase, an enzyme critical for the transcription of DNA into RNA. This inhibition prevents the bacteria from synthesizing essential proteins, ultimately leading to their death. The drug binds to the beta subunit of the RNA polymerase, which is a mechanism similar to other rifamycins.
Pharmacokinetics[edit]
Rifasutenizol is well absorbed when administered orally, with peak plasma concentrations occurring approximately 2 hours after ingestion. It is widely distributed throughout the body, including the central nervous system, which makes it effective in treating meningitis caused by susceptible organisms. The drug is metabolized in the liver and excreted primarily in the bile.
Clinical Uses[edit]
Rifasutenizol is indicated for the treatment of various bacterial infections, including:
It is often used in combination with other antibiotics to prevent the development of antibiotic resistance.
Side Effects[edit]
Common side effects of rifasutenizol include:
Serious side effects may include hepatotoxicity, hypersensitivity reactions, and hematological disorders. Patients are advised to monitor liver function regularly during treatment.
Drug Interactions[edit]
Rifasutenizol can interact with several other medications, including:
These interactions may reduce the effectiveness of the co-administered drugs or increase the risk of adverse effects.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
